Back to Search
Start Over
Evaluation of Rifalazil in Long-Term Treatment Regimens for Tuberculosis in Mice
- Source :
- Antimicrobial Agents and Chemotherapy. 44:1458-1462
- Publication Year :
- 2000
- Publisher :
- American Society for Microbiology, 2000.
-
Abstract
- Previous experiments with rifalazil (RLZ) (also known as KRM-1648) in combination with isoniazid (INH) demonstrated its potential for short-course treatment of Mycobacterium tuberculosis infection. In this study we investigated the minimum RLZ-INH treatment time required to eradicate M. tuberculosis in a murine model. RLZ-INH treatment for 6 weeks or longer led to a nonculturable state. Groups of mice treated in parallel were killed following an observation period to evaluate regrowth. RLZ-INH treatment for a minimum of 10 weeks was necessary to maintain a nonculturable state through the observation period. Pyrazinamide (PZA) was added to this regimen to determine whether the treatment duration could be further reduced. In this model, the addition of PZA did not shorten the duration of RLZ-INH treatment required to eradicate M. tuberculosis from mice. The addition of PZA reduced the number of mice in which regrowth occurred, although the reduction was not statistically significant.
- Subjects :
- Tuberculosis
Pharmacology
Mycobacterium tuberculosis
Mice
chemistry.chemical_compound
medicine
Animals
Experimental Therapeutics
Pharmacology (medical)
Antibiotics, Antitubercular
biology
business.industry
Rifalazil
Isoniazid
Drug interaction
Pyrazinamide
bacterial infections and mycoses
medicine.disease
biology.organism_classification
Rifamycins
Rifapentine
Regimen
Infectious Diseases
chemistry
Immunology
business
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 44
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....7d322504d02e320da44e875796b3e96d